1887

Abstract

Summary

Polioviruses possess three major antigenic sites which have been located chemically and structurally on the particle. One of these sites, designated site 1, is strongly immunodominant for serotype 3, but highly immunorecessive for type 1. We report that monoclonal antibodies directed against site 1 of type 1 poliovirus may be isolated by an altered route of immunization of the donor mice. Site 1 is shown to be highly variable for type 1, but highly conserved for type 3 poliovirus, although the converse would be predicted from their immunodominance. The evidence presented suggests that the antigenic conservation is associated with a strong selective pressure for a proteolytic cleavage site within site 1 of type 3. As proteolytic cleavage results in the loss of the antigenicity of site 1 the presence of the cleavage site in a virus replicating in the gut in the presence of proteases would protect the virus from neutralizing antibodies directed against uncleaved site 1. The conservation of the site in type 3 is thus consistent with the view that site 1 is a significant target of a human as well as a murine immune response against type 3.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-7-1857
1987-07-01
2021-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/7/JV0680071857.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-7-1857&mimeType=html&fmt=ahah

References

  1. Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. 1983; Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and heat-inactivated virions. Virology 126:707–710
    [Google Scholar]
  2. Blondel B., Crainic R., Fichot O., Dufraisse G., Cardrea A, Horaud F. 1986; Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody binding site. Journal of Virology 57:81–90
    [Google Scholar]
  3. Diamond D. C., Jameson B. A., Brown J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Osterhaus A. D. M. E., Crainic R., Nomoto A., Wimmer E. 1985; Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229:1090–1093
    [Google Scholar]
  4. Evans D. M. A., Minor P. D., Schild G. C., Almond J. W. 1983; Critical role of an eight amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature; London: 304459–462
    [Google Scholar]
  5. Ferguson M., Qi Y-H., Minor P. D., Magrath D. I., Spitz M., Schild G. C. 1982; Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet ii:122–124
    [Google Scholar]
  6. Ferguson M., Minor P. D., Magrath D. I., Qi Y-H., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
    [Google Scholar]
  7. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction of broadly reactive type specific neutralising antibody to poliovirus type 3 by synthetic peptides. Virology 143:505–515
    [Google Scholar]
  8. Fox J. P. 1958; Epidemiology of poliomyelitis in populations before and after vaccination with inactivated viruses. In Poliomyelitis: Papers and Discussions Presented at the Fourth International Poliomyelitis Congress pp. 136–149 Philadelphia: J. B. Lippincott Company;
    [Google Scholar]
  9. Fricks C. E., Icenogle J. P., Hogle J. M. 1985; Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. Journal of Virology 54:856–859
    [Google Scholar]
  10. Gearing A. J. H., Thorpe R., Spitz L., Spitz M. 1985; Use of ‘single shot’ intrasplenic immunization technique for the production of monoclonal antibodies specific for human IgM. Journal of Immunological Methods 76:337–343
    [Google Scholar]
  11. Hogle J. M., Chow M., Filman D. J. 1985; The three dimensional structure of poliovirus at 2·9 Å resolution. Science 229:1358–1365
    [Google Scholar]
  12. Huovilainen A., Hovi T., Kinnunen L., Takkinen K., Ferguson M., Minor P. 1987; Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. Journal of General Virology 68:1373–1378
    [Google Scholar]
  13. Icenogle J. P., Minor P. D., Ferguson M., Hogle J. M. 1986; Modulation of humoral response to a 12-amino acid site on the poliovirion. Journal of Virology 60:297–301
    [Google Scholar]
  14. Magrath D. I., Evans D. M. A., Ferguson M., Schild G. C., Minor P. D., Horaud F., Crainic R., Stenvik M., Hovi T. 1986; Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. Journal of General Virology 67:899–905
    [Google Scholar]
  15. Makoff A. j., Paynter C. A., Rowlands D. J., Boothroyd J. C. 1982; Comparison of the amino acid sequence of the major immunogen from three serotypes of foot-and-mouth disease virus. Nucleic Acids Research 10:8285–8295
    [Google Scholar]
  16. Minor P. D. 1980; Comparative biochemical studies of type 3 poliovirus. Journal of Virology 34:73–84
    [Google Scholar]
  17. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R., Clarke L. D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralization. Nature; London: 301674–679
    [Google Scholar]
  18. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
    [Google Scholar]
  19. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986a; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
  20. Minor P. D., John A., Ferguson M., Icenogle J. P. 1986b; Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. Journal of General Virology 67:693–706
    [Google Scholar]
  21. Nathanson N., Martin J. R. 1979; The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity and disappearance. American Journal of Epidemiology 110:672–697
    [Google Scholar]
  22. Nomoto A., Omata T., Toyoda H., Kuge S., Horie H., Kataoka Y., Genda X., Nakano Y., Imura N. 1982; Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proceedings of the National Academy of Sciences, U.S.A 79:5793–5797
    [Google Scholar]
  23. Wiley D. C., Wilson I. A., Skehel J. J. 1981; Structural identification of the antibody binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature; London: 289373–378
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-7-1857
Loading
/content/journal/jgv/10.1099/0022-1317-68-7-1857
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error